Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 156,609 | 145,033 | 143,483 | 148,069 | 153,647 |
| Cost of Goods | 113,021 | 107,537 | 107,153 | 109,999 | 112,814 |
| Gross Profit | 43,588 | 37,496 | 36,330 | 38,070 | 40,833 |
| Operating Expenses | 20,070 | 15,237 | 14,995 | 18,842 | 18,707 |
| Operating Income | 23,539 | 22,796 | 21,488 | 20,227 | 22,940 |
| Interest Expense | 2,618 | 2,548 | 2,569 | 3,021 | 3,434 |
| Pre-tax Income | 20,921 | 20,248 | 18,919 | 17,206 | 19,506 |
| Income Tax | 2,929 | 3,714 | 2,081 | 671 | 4,389 |
| Net Income Continuous | 17,992 | 16,534 | 16,838 | 16,535 | 15,117 |
| Net Income Discontinuous | -310 | N/A | N/A | N/A | N/A |
| Minority Interests | 24 | -90 | 108 | -89 | 35 |
| Net Income | $17,658 | $15,459 | $16,730 | $16,624 | $15,082 |
| EPS Basic Total Ops | 0.40 | 0.35 | 0.38 | 0.38 | 0.36 |
| EPS Basic Continuous Ops | 0.41 | 0.38 | 0.38 | 0.38 | 0.36 |
| EPS Basic Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.40 | 0.35 | 0.38 | 0.38 | 0.35 |
| EPS Diluted Continuous Ops | 0.41 | 0.37 | 0.38 | 0.38 | 0.36 |
| EPS Diluted Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $29,843 | $29,346 | $28,212 | $26,978 | $29,787 |